top of page

India Drug Approvals | 2024 | CDSCO | News | Updates | Media | iPharmaCenter

Vonoprazan approved in India
India drug approvals

19th January, 2024


Recommended alongside dietary adjustments and physical activity to enhance blood sugar management in grown-ups with type 2 diabetes.


02 February, 2024

Plazomicin injection

Plazomicin injection at a concentration of 500mg per 10ml (50mg per ml): Suitable for individuals aged 18 years and above for addressing intricate urinary tract infections (cUTI), such as pyelonephritis provoked by certain susceptible microorganisms:

  • Escherichia coli,

  • Klebsiella pneumoniae,

  • Proteus mirabilis, and

  • Enterobacter cloacae


21 March, 2024

Etifoxine Hydrochloride

Etifoxine Hydrochloride capsules at 50 mg: Designed for alleviating psychosomatic symptoms of anxiety.


08 May 2024


Vonoprazan: Intended for managing reflux esophagitis (RE), gastric ulcers (GU), duodenal ulcers (DU), and as a preventive measure against the recurrence of gastric or duodenal ulcers amidst low-dose aspirin or NSAIDs intake. Additionally, it serves as a supportive treatment for Helicobacter pylori eradication in the context of:

  • Gastric ulcers

  • Duodenal ulcers

  • Gastric mucosa-associated lymphoid tissue (MALT) lymphoma

  • Idiopathic thrombocytopenic purpura

  • Stomach conditions post-endoscopic resection of early-stage cancer

  • Helicobacter pylori gastritis


Recent Posts

See All

Australia Healthcare News | Media | Updates

New medications, Jemperli and Korsuva will be available for endometrial cancer and chronic kidney disease For women facing advanced or recurring endometrial cancer, a medication called Jemperli (dosta


bottom of page